secwatch.observer — SEC 8-K summary
======================================

Issuer:     InfuSystem Holdings, Inc (INFU)
CIK:        0001337013
Form:       8-K
Filed at:   2025-03-04T23:59:59+00:00
Accession:  0001628280-25-009610
Event type: earnings
Sentiment:  positive
Materiality: 0.75
Item codes: 2.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

InfuSystem reports record 2024 revenue of $134.9M, +7% YoY; Adj EBITDA +13% to $25.3M; guides 2025 revenue growth 8-10%
--------------------------------------------------------------------------------

- Q4 net revenues $33.8M (+7% YoY); net income $0.9M ($0.04 EPS) vs $0.1M prior year.
- Full year adj EBITDA $25.3M (+13%); operating cash flow $20.5M (+82%).
- Patient Services rev $80.4M (+5%), Device Solutions $54.5M (+11%) for full year.
- 2025 guidance: revenue growth 8-10%, adj EBITDA margin above 18.8%.
- Repurchased $1.2M in 2024 and ~$2.4M in Q1 2025; net debt down $5.5M to $23.3M.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1337013/000162828025009610/0001628280-25-009610-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1337013/000162828025009610/infu-20250304.htm
  HTML page:      https://secwatch.observer/filing/0001628280-25-009610

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer